nasdaq:cbmg
|
2842891
|
Mar 24th, 2024 12:00AM
|
Celllular Biomedicine Group
|
431
|
6.00
|
Open
|
|
Mar 24th, 2024 12:05AM
|
Mar 24th, 2024 12:05AM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 23rd, 2024 12:00AM
|
Celllular Biomedicine Group
|
431
|
6.00
|
Open
|
|
Mar 22nd, 2024 11:11PM
|
Mar 23rd, 2024 06:30PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 22nd, 2024 12:00AM
|
Celllular Biomedicine Group
|
431
|
6.00
|
Open
|
|
Mar 21st, 2024 11:10PM
|
Mar 22nd, 2024 06:18PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 21st, 2024 12:00AM
|
Celllular Biomedicine Group
|
432
|
6.00
|
Open
|
|
Mar 20th, 2024 11:17PM
|
Mar 21st, 2024 05:01PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 20th, 2024 12:00AM
|
Celllular Biomedicine Group
|
431
|
6.00
|
Open
|
|
Mar 19th, 2024 11:32PM
|
Mar 20th, 2024 07:02PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 19th, 2024 12:00AM
|
Celllular Biomedicine Group
|
430
|
6.00
|
Open
|
|
Mar 18th, 2024 10:58PM
|
Mar 19th, 2024 05:34PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 18th, 2024 12:00AM
|
Celllular Biomedicine Group
|
429
|
6.00
|
Open
|
|
Mar 17th, 2024 11:20PM
|
Mar 18th, 2024 06:46PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 17th, 2024 12:00AM
|
Celllular Biomedicine Group
|
429
|
6.00
|
Open
|
|
Mar 17th, 2024 12:04AM
|
Mar 17th, 2024 12:04AM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 16th, 2024 12:00AM
|
Celllular Biomedicine Group
|
429
|
6.00
|
Open
|
|
Mar 15th, 2024 10:46PM
|
Mar 16th, 2024 06:34PM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cbmg
|
2842891
|
Mar 15th, 2024 12:00AM
|
Celllular Biomedicine Group
|
430
|
6.00
|
Open
|
|
Mar 14th, 2024 11:49PM
|
Mar 15th, 2024 08:21AM
|
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.
|
Open
|
Biomedicine, Progenitor Cells, Embryonic Stem Cells, and Dendritic Cells
|
Open
|
张江法拉第路85号3号楼
|
上海
|
上海
|
CN
|
201210
|
|
Cellular Biomedicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|